Rapid Test Kit QuickVue Infectious Disease Immunoassay Acute Conjunctivitis (Pink Eye) Tear Sample 10 Tests CLIA Waived

By Mckesson
0
(0)
0 147
$377.44
In Stock

1127861

Description

QuickVue Adenoviral conjunctivitis Test is a CLIA-waived test for the visual, qualitative in vitro detection of Adenoviral antigens (hexon protein) directly from eye fluid. Identify, isolate and manage contagious patients, preventing spread to other patients and staff. Offers an accurate, fast, disposable platform that is easy to use. 90% sensitivity and 96% specificity. Disposable test. No additional equipment is needed to administer or interpret


Specification

  • Application : Rapid Test Kit
  • CLIA Classification : CLIA Waived
  • Contents 1 : (10) Individually Packaged Sample Collector, (10) Individually Packaged Test Cassette, (10) Buffer Vial, Package Insert
  • Number of Tests : 10 Tests
  • Product Dating : McKesson Acceptable Dating: we will ship >= 90 days
  • Reading Type : Visual Read
  • Sample Type : Tear Sample
  • Technology : Direct Sampling Micro-Filtration Technology
  • Test Format : Cassette Format
  • Test Method : Lateral Flow Method
  • Test Name : Acute Conjunctivitis (Pink Eye)
  • Test Type : Infectious Disease Immunoassay
  • Time to Results : 10 Minute Results
  • UNSPSC Code : 41116144

Attachment : Product Specification Sheet

Vendor McKesson
Price Range $201 - $300
Shipping Cost
Shop Location Irving, Texas (TX), United States (US)

No reviews found!

No comments found for this product. Be the first to comment!

Welcome to shop.mhsurgicals.com..! In order to provide a more relevant experience for you, we use cookies to enable some website functionality. Cookies help us see which articles most interest you. This website or its third-party tools process personal data (e.g. browsing data or IP addresses) and use cookies or other identifiers, which are necessary for its functioning and required to achieve the purposes illustrated in the cookie policy.

You accept the use of cookies by closing or dismissing this notice, To learn more, please refer to the Cookie policy.